FibroNox
PrivateLast Round
Grant
Jun 1, 2024
Total Funding Raised
$2.58M
Company Overview
FibroNox operates in Healthcare & Life Sciences and is based in Milton, Georgia. Its latest recorded funding round was a Grant round in June 2024.
FibroNox is a biotechnology company that develops selective Nox4 inhibitors and Nrf2 activators to treat fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FibroNox Comparables
Compare FibroNox with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glucox Biotech AB | 78% | |
| Asahi Kasei | 73% | |
| Tvardi | 73% |
For institutional investors. Book with your work email.
FibroNox Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 1, 2024 | ||||
| Grant | May 15, 2024 | ||||
| Grant | Sep 15, 2020 | ||||
| Accelerator | Feb 26, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
FibroNox Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Heart, Lung, and Blood Institute | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2026
Monthly visitors grew 484% MoM, reaching 1K.
- Jun 1, 2024
$2M grant from National Heart, Lung, and Blood Institute and NIH.
For institutional investors. Book with your work email.
FibroNox Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FibroNox's valuation, stock price, and market status.
Is FibroNox a public or private company?
FibroNox is a private company.
What is the current stock price of FibroNox?
FibroNox is a private company, so its shares have no public market price. Caplight tracks FibroNox's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FibroNox worth (valuation)?
Valuation information for FibroNox is not publicly available.
Can I buy FibroNox stock?
FibroNox shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FibroNox's last funding round?
FibroNox's most recent funding round was Grant on June 1, 2024.
Who are the main investors in FibroNox?
Key investors in FibroNox include National Heart, Lung, and Blood Institute.
Will FibroNox IPO soon?
No public IPO plans have been announced for FibroNox.
How can I track FibroNox secondary market activity?
Caplight tracks bids, offers, and trades in FibroNox's shares on secondary markets.